サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1293680

前臨床CRO市場：サービス別、用途別、エンドユーザー別-2023～2030年の世界予測

Preclinical CRO Market by Services, Application, End-User - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 186 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
前臨床CRO市場：サービス別、用途別、エンドユーザー別-2023～2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

前臨床CROの世界市場は、2023年に58億3,080万米ドル、CAGR 9.65%で大きく成長し、2030年には111億3,765万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の前臨床CRO市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：ロシア・ウクライナ紛争、高インフレに関する包括的な理解を提供します。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.前臨床CROの世界市場規模および予測は？

2.予測期間中、世界の前臨床CRO市場を形成するCOVID-19の阻害要因と影響は？

3.前臨床CROの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.前臨床CROの世界市場における競争戦略は？

5.前臨床CROの世界市場における技術動向と規制の枠組みは？

6.前臨床CROの世界市場における主要ベンダーの市場シェアは？

7.前臨床CROの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 新しい薬や治療法を開発するための製薬会社やバイオ医薬品会社別研究開発活動の増加
      • 製薬会社のCROへの医薬品開発業務委託の増加傾向
      • 個別化医療の開発への注目の高まり
    • 抑制要因
      • 前臨床CROサービスに関連する高コストと時間のかかる制約
    • 機会
      • より効率的で費用対効果の高い前臨床調査を可能にする技術の進歩が進む
      • モノクローナル抗体、ワクチン、細胞治療などの生物製剤の前臨床調査の高い可能性
    • 課題
      • 国際規制当局別定められた厳格な規制とガイドライン
  • 市場動向
    • 南北アメリカにおける老舗の製薬会社およびバイオ医薬品会社の存在と、先進的な前臨床CROプラットフォームのイントロダクションの増加
    • アジア太平洋地域における新薬や医療機器の開発に向けた研究開発活動の拡大に対する政府の支援の増加
    • 医薬品開発活動に対する政府の資金提供の可能性により、EMEA地域での前臨床CROビジネスが拡大します。
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 前臨床CRO市場：サービス別

  • イントロダクション
  • 生物分析とDMPK研究
  • 毒性試験

第7章 前臨床CRO市場：用途別

  • イントロダクション
  • 循環器疾患
  • 皮膚科
  • 胃腸
  • 泌尿生殖器と女性の健康
  • 血液学
  • 免疫疾患
  • 感染症
  • 代謝障害
  • 神経内科
  • 腫瘍学
  • 眼科
  • 呼吸器疾患

第8章 前臨床CRO市場：エンドユーザー別

  • イントロダクション
  • バイオ医薬品企業
  • 政府および学術機関
  • 医療機器企業

第9章 南北アメリカの前臨床CRO市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の前臨床CRO市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの前臨床CRO市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別
    • 合併・買収
    • 契約、コラボレーション、パートナーシップ
    • 新製品発売と機能強化
    • 投資、資金調達
    • 受賞・表彰・拡大

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. PRECLINICAL CRO MARKET RESEARCH PROCESS
  • FIGURE 2. PRECLINICAL CRO MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PRECLINICAL CRO MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2022 VS 2030 (%)
  • FIGURE 5. PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. PRECLINICAL CRO MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. PRECLINICAL CRO MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. PRECLINICAL CRO MARKET DYNAMICS
  • FIGURE 9. PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. PRECLINICAL CRO MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. PRECLINICAL CRO MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. PRECLINICAL CRO MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PRECLINICAL CRO MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PRECLINICAL CRO MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 5. PRECLINICAL CRO MARKET SIZE, BY BIOANALYSIS & DMPK STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. PRECLINICAL CRO MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. PRECLINICAL CRO MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. PRECLINICAL CRO MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PRECLINICAL CRO MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. PRECLINICAL CRO MARKET SIZE, BY GENITOURINARY & WOMEN'S HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PRECLINICAL CRO MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PRECLINICAL CRO MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. PRECLINICAL CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. PRECLINICAL CRO MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. PRECLINICAL CRO MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. PRECLINICAL CRO MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. PRECLINICAL CRO MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. PRECLINICAL CRO MARKET SIZE, BY GOVERNMENT & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. PRECLINICAL CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. PRECLINICAL CRO MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 152. PRECLINICAL CRO MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 153. PRECLINICAL CRO MARKET LICENSE & PRICING
目次
Product Code: MRR-A339DAEFA52E

The Global Preclinical CRO Market is forecasted to grow significantly, with a projected USD 5,830.80 million in 2023 at a CAGR of 9.65% and expected to reach a staggering USD 11,137.65 million by 2030.

The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Preclinical CRO Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Preclinical CRO Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Services, market is studied across Bioanalysis & DMPK Studies and Toxicology Testing. The Bioanalysis & DMPK Studies commanded largest market share of 43.84% in 2022, followed by Toxicology Testing.

Based on Application, market is studied across Cardiovascular Disease, Dermatology, Gastrointestinal, Genitourinary & Women's Health, Hematology, Immunological Disorders, Infectious Diseases, Metabolic Disorders, Neurology, Oncology, Ophthalmology, and Respiratory Disorders. The Oncology commanded largest market share of 13.21% in 2022, followed by Immunological Disorders.

Based on End-User, market is studied across Biopharmaceutical Companies, Government & Academic Institutes, and Medical Device Companies. The Biopharmaceutical Companies commanded largest market share of 66.13% in 2022, followed by Medical Device Companies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 40.50% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Preclinical CRO Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Preclinical CRO Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Preclinical CRO Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Preclinical CRO Market?

4. What is the competitive strategic window for opportunities in the Global Preclinical CRO Market?

5. What are the technology trends and regulatory frameworks in the Global Preclinical CRO Market?

6. What is the market share of the leading vendors in the Global Preclinical CRO Market?

7. What modes and strategic moves are considered suitable for entering the Global Preclinical CRO Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Preclinical CRO Market, by Services, 2022 vs 2030
  • 4.3. Preclinical CRO Market, by Application, 2022 vs 2030
  • 4.4. Preclinical CRO Market, by End-User, 2022 vs 2030
  • 4.5. Preclinical CRO Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing R&D activities by pharmaceutical and biopharmaceutical companies to develop new drugs & therapies
      • 5.1.1.2. Rising trend of outsourcing drug development activities to CROs by pharmaceutical companies
      • 5.1.1.3. Growing focus on the development of personalized medicines
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and time-consuming constraints associated with preclinical CRO services
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing advances in technologies to enable more efficient and cost-effective preclinical research
      • 5.1.3.2. High potential for preclinical research for biologics, including monoclonal antibodies, vaccines, and cell therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and guidelines set by international regulatory authorities
  • 5.2. Market Trends
    • 5.2.1. Presence of well-established pharmaceutical & biopharmaceutical companies and the rising introduction of advanced preclinical CRO platforms in the Americas
    • 5.2.2. Rising government support for expanding research & development activities into developing new drugs and medical devices in the Asia-Pacific region
    • 5.2.3. Potential government funding in drug development activities expands the preclinical CRO business in the EMEA region.
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Preclinical CRO Market, by Services

  • 6.1. Introduction
  • 6.2. Bioanalysis & DMPK Studies
  • 6.3. Toxicology Testing

7. Preclinical CRO Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular Disease
  • 7.3. Dermatology
  • 7.4. Gastrointestinal
  • 7.5. Genitourinary & Women's Health
  • 7.6. Hematology
  • 7.7. Immunological Disorders
  • 7.8. Infectious Diseases
  • 7.9. Metabolic Disorders
  • 7.10. Neurology
  • 7.11. Oncology
  • 7.12. Ophthalmology
  • 7.13. Respiratory Disorders

8. Preclinical CRO Market, by End-User

  • 8.1. Introduction
  • 8.2. Biopharmaceutical Companies
  • 8.3. Government & Academic Institutes
  • 8.4. Medical Device Companies

9. Americas Preclinical CRO Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Preclinical CRO Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Preclinical CRO Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Merger & Acquisition
      • 12.3.1.1. AmplifyBio Expands Cell Therapy Characterization, Fills Gap in Preclinical Development
      • 12.3.1.2. Clinchoice Continues Expansion with CRO Acquisition
      • 12.3.1.3. CRO Avania Acquires MAXIS
      • 12.3.1.4. Apax Acquires a Majority Stake in Porsolt to Support its Growth Strategy and Become a Global Leader in Preclinical Services
    • 12.3.2. Agreement, Collaboration, & Partnership
      • 12.3.2.1. Cryoport Announces Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
      • 12.3.2.2. Crown Bioscience and ERS Genomics Announce Global CRISPR/Cas9 Licensing Agreement for Genome Editing Patents
      • 12.3.2.3. Domain Therapeutics and Explicyte Enter Partnership Agreement in Immuno-Oncology
      • 12.3.2.4. Hera BioLabs Announces Exclusive Global License With Charles River
      • 12.3.2.5. IonsGate Preclinical Services and InSilicoTrials Form Partnership
    • 12.3.3. New Product Launch & Enhancement
      • 12.3.3.1. PsychoGenics Launches eCube, a New AI-Enabled Platform for Drug Discovery
    • 12.3.4. Investment & Funding
      • 12.3.4.1. CRO Company TriApex Completes Series C Financing Round Led by Legend Capital
      • 12.3.4.2. ClinChoice Raises USD 150 Million in Series E Round
    • 12.3.5. Award, Recognition, & Expansion
      • 12.3.5.1. Proscia Announces Major Expansion in Preclinical R&D to Drive Faster Drug Safety Decisions
      • 12.3.5.2. ​​QPS opens an additional preclinical research facility in Taiwan
      • 12.3.5.3. Celerion Expands Early Phase Clinical Pharmacology Units

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

1. 10x Genomics, Inc.

2. AmplifyBio

3. Atuka Inc.

4. BenchSci

5. Bioserve Biotechnologies (India) PVT Ltd. by REPROCELL Inc.

6. Biotrofix, Inc.

7. Celerion

8. Charles River Laboratories International, Inc.

9. Crown Bioscience, Inc.

10. CTI Clinical Trial and Consulting, Inc.

11. Diag2Tec SAS

12. Eurofins Scientific SE

13. F. Hoffmann-La Roche Ltd.

14. Gubra

15. Hera Biolabs

16. ICON PLC

17. Immusmol SAS

18. ImQuest BioSciences

19. Inotiv, Inc.

20. Intertek Group PLC

21. Invivotek by Genesis Biotechnology Group, LLC

22. IQVIA Inc.

23. Jubilant Biosys Ltd. byJubilant Pharmova Limited Company

24. Laboratory Corporation of America Holding

25. MCI Group Holding SA

26. MD Biosciences

27. Medpace Holdings, Inc.

28. Novartis AG

29. Parexel International Corporation.

30. PharmaCircle LLC

31. Phenos GmbH

32. PPD by Thermo Fisher Scientific Inc.

33. PsychoGenics Inc.

34. QPS Holdings, LLC

35. Sanofi S.A.

36. SCiAN Services Inc.

37. SGS SA

38. Shanghai Medicilon Inc.

39. Syneos Health, Inc.

40. Transpharmation

41. Veristat, LLC

42. Vimta Labs Limited

43. WuXi AppTec Co., Ltd.